CVMs management based on imaging genomics and liquid biopsy. (IMAGE)

Sichuan International Medical Exchange and Promotion Association

CVMs management based on imaging genomics and liquid biopsy.

Caption

In the future, somatic or de novo germline mutation information could be used to direct neurosurgical and medical management of CVMs. Somatic or germline variants can be acquired from imaging genomics or liquid biopsies preoperatively. These variants could then be correlated with clinical demographics and medical history to expand research efforts and identify targeted therapies or immunotherapy that could be used as monotherapy or adjuncts to surgery. This information could also be used for surgical planning if necessary.

Credit

Dr. Yong Cao and Dr. Jizong Zhao

Usage Restrictions

Please cite source.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.